Marquard Imfeld

Title: Marquard Imfeld: Innovator in Asymmetric Hydrogenation and Hydroquinone Derivatives

Introduction

Marquard Imfeld is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of chemistry, particularly in the development of processes that enhance the production of valuable compounds. With a total of 3 patents to his name, Imfeld's work is recognized for its innovative approaches and practical applications.

Latest Patents

Imfeld's latest patents include an asymmetric hydrogenation process using ruthenium-diphosphine complexes. This process allows for the asymmetric hydrogenation of specific compounds, resulting in the formation of enantiomers that are crucial in various chemical applications. Another significant patent focuses on hydroquinone derivatives that are useful in the production of vitamin E. These novel derivatives serve as intermediates in the manufacture of both natural and racemic forms of α-tocopherol, showcasing Imfeld's commitment to advancing chemical synthesis.

Career Highlights

Throughout his career, Marquard Imfeld has been associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical and biotechnology sectors. His work has contributed to the development of innovative solutions that address complex challenges in chemical production and synthesis.

Collaborations

Imfeld has collaborated with esteemed colleagues such as Henri Ramuz and Peter Vogt. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their collective work.

Conclusion

Marquard Imfeld's contributions to the field of chemistry, particularly in asymmetric hydrogenation and hydroquinone derivatives, highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to developing processes that have practical applications in the industry.